coronarophraphy in patients with CKD stage I-II.
Methods: In
randomized, sham-
controlled blind study 51 patient
variability. In the
randomized, sham-
controlled, crossover blind design study, a group
of 30 coronary heart
of clinical
trials. According to these studies number of adverse outcomes comparable with adverse outcomes
YARULLINA, L.G.,
KASIMOVA, R.I.,
AKHATOVA, A.R.,
MAKSIMOV, I.V.,
IBRAGIMOV, R.I.,
TSVETKOV, V.O.,
YARULLINA, L.M. (2016) .). The development of the fungus in
control and pretreated by chitooligosacharides wheat leaves was estimated